Concepedia

Author

David Mutimer

Queen Elizabeth Hospital Birmingham

Also Known As

Clifford Leen, D MUTIMER, D Mutimer, D. MUTIMER, D. Mutimer, David Mutimer, David Mutimer Mutimer

40

Publications

1.1K

Citations

14

H-Index

17

Concepts

All Affiliations

Queen Elizabeth Hospital BirminghamUniversity of Birmingham
DM

About

David Mutimer is an author at Queen Elizabeth Hospital Birmingham specializing in medicine, viral hepatitis, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

51

2

Hepatology

1

1

11

3

Immunology

1

1

19

4

Dna Replication

1

1

21

5

Genetics

1

1

21

David Mutimer

×

12

Publications

769

Citations

11

H-Index

YearCitations

Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C

M Wali, Rebecca Harrison, Paul Gow,

Gut

2002

274

LAMIVUDINE WITHOUT HBIg FOR PREVENTION OF GRAFT REINFECTION BY HEPATITIS B: LONG-TERM FOLLOW-UP

David Mutimer, Geoffrey Dusheiko, Catherine Barrett,

Transplantation

2000

161

Outcome of liver transplantation for patients with pulmonary hypertension

Peter Stärkel, Alonso Vera, Bridget Gunson,

Liver Transplantation

2002

97

ENHANCED (CYTOMEGALOVIRUS) VIRAL REPLICATION ASSOCIATED WITH SEPTIC BACTERIAL COMPLICATIONS IN LIVER TRANSPLANT RECIPIENTS

David Mutimer, Darius F. Mirza, Jean Shaw,

Transplantation

1997

54

Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans

Christabel Kelly, Leo Swadling, Stefania Capone,

Hepatology

2015

52

QUANTITATION OF EPSTEIN-BARR VIRUS DNA IN THE BLOOD OF ADULT LIVER TRANSPLANT RECIPIENTS1

David Mutimer, Narinder Kaur, Howard Tang,

Transplantation

2000

34

Incidence and characterization of serum transaminases elevations in pegylated interferon and ribavirin treated patients with chronic hepatitis C

Prem Harichander Thurairajah, Douglas Thorburn, S.G. Hübscher,

Alimentary Pharmacology & Therapeutics

2007

21

Mutations in the hepatitis B virus DNA polymerase associated with antiviral resistance

Deenan Pillay, Angeline Bartholomeusz, Patricia Cane,

1998

21

PS-078-A phase 1b evaluation of HepTcell HBV-specific immunotherapy in nuc-controlled, eAg negative chronic HBV infection

Young-Suk Lim, David Mutimer, Jeong Heo,

Journal of Hepatology

2019

19

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence

Philippe J. Zamor, Ashley Brown, Douglas E. Dylla,

The American Journal of Gastroenterology

2021

13

Page 1